Eterna Therapeutics

Price & Volume

Stats

52W Range	$1.08-$14.40
Market Cap	$10.9M
Shares Short	118,475

Financials

Revenue (12 Mos)	$1,000
Revenue Growth (YoY)	-94.1%
Gross Profit (12 Mos)	$1,000
Diluted EPS	$56.32

News

Yahoo Finance • last month

Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer

Yahoo Finance • last month

Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG

Yahoo Finance • 2 months ago

Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials

Yahoo Finance • 2 months ago

Ernexa Therapeutics Showcases Strategic Partnership with Cellipont Bioservices to Advance Toward First-in-Human Trials on Virtual Investor “What This Means” Platform

About

CEO	Mr. Sanjeev Luther
Address	1035 Cambridge Street, Cambridge, MA, United States, 02141
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	6